Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

Journal of Neuroscience

Volumn 20, Issue 24, 2000, Pages 9126-9134

  Eberhardt, Olaf ^a   Coelln, Rainer V ^a   Kügler, Sebastian ^a   Lindenau, Jörg ^a   Rathke Hartlieb, Silvia ^a   Gerhardt, Ellen ^a   Haid, Sibylle ^a   Isenmann, Stefan ^a   Gravel, Claude ^b   Srinivasan, Anu ^c   Bähr, Mathias ^a   Weller, Michael ^a   Dichgans, Johannes ^a   Schulz, Jörg B ^a,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^c PFIZER INC   (United States)

^d Department of Neurology ^*  (Germany)

Author keywords

Apoptosis; Caspases; Gene therapy; Glial cell line derived neurotrophic factor; Parkinson's disease; X chromosome linked inhibitor of apoptosis

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG POTENTIATION; EMBRYO; GENE TRANSFER; MALE; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; X CHROMOSOME LINKAGE;

EID: 0034671450     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-24-09126.2000     Document Type: Article

References (55)

1. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
2. Aging, energy and oxidative stress in neurodegenerative diseases
3. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
4. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease
5. The MPTP model: Versatile contributions to the treatment
6. Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice
7. Dopaminergic neurons protected from degeneration by GDNF gene therapy
8. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor
9. GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice
10. New animal models for Parkinson's disease
11. Genetic and metabolic status of NGF deprived sympathetic neurons saved by an inhibitor of ICE family proteases
12. IAP family proteins - Suppressors of apoptosis
13. X-linked IAP is a direct inhibitor of cell-death proteases
14. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
15. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
16. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons
17. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases
18. Functional recovery in parkinsonian monkeys treated with GDNF
19. Neuroprotective and neurorestorative properties of GDNF
20. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses
21. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons
22. The search for synergy: A critical review from a response surface perspective
23. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
24. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium
25. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
26. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system
27. Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity
28. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain
29. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease
30. Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism
31. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity
32. An adenovirus vector for gene transfer into neurons and glia in the brain
33. "Apoptotic" biochemical cascades in synaptic compartments: Roles in adaptive plasticity and neurodegenerative disorders
34. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
35. Histochemical detection of apoptosis in Parkinson's disease
36. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
37. Caspase inhibition reduces apoptosis and increases survival of nigral transplants
38. Mitochondrial dysfunction in movement disorders
39. Involvement of free radicals in excitotoxicity in vivo
40. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases
41. Potassium deprivation-induced apoptosis of cerebellar granule neurons: A sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species
42. Caspases as treatment targets in stroke and neurodegenerative diseases
43. Adenovirus-mediated gene transfer of IAPs delays apoptosis of cerebellar granule neurons
44. Adenovirus-mediated gene transfer of the tumor suppressor, p53, induces apoptosis in postmitotic neurons
45. Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3
46. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
47. 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism
48. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
49. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds
50. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
51. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests atrophic role in the adult
52. Cell death and apoptosis regulating proteins in Parkinson's disease: A cautionary note
53. MPTP neurotoxicity is attenuated in mice overexpressing Bcl-2
54. Dose response to intraventricular glial cell line derived neurotrophic factor administration in parkinsonian monkeys